About Incor Pharma and Diagnostics Private Limited
Data last updated:
Incor Pharma and Diagnostics Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Incor Hospitals Private Limited. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 22 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85110TG2012PTC084319.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shrihari Pulagam and Gautham Reddy Madduri.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground Floor Vijetha Midas Touch Apartments Sy No.6, White Field Road Kondapur Hyderabad, Telangana, India – 500084.
The company has 1 deal on record (1 secondary share transfer); the latest was in December 2013.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website incor.in.
CIN History of Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics has one previous CIN (Corporate Identification Number): U85110AP2012PTC084319. The current CIN is U85110TG2012PTC084319, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110TG2012PTC084319 | Current |
| U85110AP2012PTC084319 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressGround Floor Vijetha Midas Touch Apartments Sy No.6, White Field Road Kondapur Hyderabad, Telangana, India – 500084
- IndustryHealthcare, Hospitals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Incor Pharma and Diagnostics Private Limited FY 2025 filings available
Financial Statement Summary of Incor Pharma and Diagnostics Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Incor Pharma and Diagnostics Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Incor Pharma and Diagnostics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrihari Pulagam | Director | 25 May 2022 | 4 Years 4 Months | Current |
| Gautham Reddy Madduri Also directs: Omnipharm Laboratories Private Limited | Director | 22 Nov 2012 | 13 Years 11 Months | Current |
Auditor Details of Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics Private Limited is audited by K C P & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K C P & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Incor Pharma and Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics Private Limited has 1 deal on record (1 secondary share transfer); the latest was in December 2013.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2013 | Secondary share transfer | Undisclosed | Buyer: Incor Hospitals Private Limited Seller: an individual |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Incor Pharma and Diagnostics Private Limited
Employment history and EPFO contributions of people linked to Incor Pharma and Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Shrihari Pulagam ceased to be Additional Director on 26 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Incor Pharma and Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Incor Pharma and Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Incor Pharma and Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Incor Pharma and Diagnostics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Incor Pharma and Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Incor Pharma and Diagnostics Private Limited
Frequently Asked Questions about Incor Pharma and Diagnostics Private Limited
Incor Pharma and Diagnostics is an active private limited company based in Hyderabad, Telangana, India. The company works in hospitals, within the healthcare industry. It was incorporated on 22 November 2012 (14+ years old) and is registered under CIN U85110TG2012PTC084319.
Incor Pharma and Diagnostics has 2 current directors:
- Shrihari Pulagam - Director
- Gautham Reddy Madduri - Director
The CIN (Corporate Identification Number) of Incor Pharma and Diagnostics is U85110TG2012PTC084319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Incor Pharma and Diagnostics was incorporated on 22 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Incor Pharma and Diagnostics has 1 deal on record (1 secondary share transfer); the latest was in December 2013.
Shrihari Pulagam ceased to be Additional Director on 26 Sep 2022. Shrihari Pulagam was appointed as Director on 25 May 2022. Upendar Reddy Singatala ceased to be Director on 25 May 2022. Incor Pharma and Diagnostics has 5 board changes on record in total.
Incor Pharma and Diagnostics can be reached through the website incor.in. Its registered office is in Hyderabad, Telangana, India.
The registered office of Incor Pharma and Diagnostics is at Ground Floor Vijetha Midas Touch Apartments Sy No.6, White Field Road Kondapur Hyderabad, Telangana, India – 500084.
Incor Pharma and Diagnostics has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh.
Incor Pharma and Diagnostics operates in the healthcare industry, in the hospitals segment.